Search results for "Human immunodeficiency viru"

showing 10 items of 175 documents

Peer Support for People Living With HIV: A Scoping Review

2021

Peer support for people living with HIV has gained increasing traction and is considered a way to take an active role in self-management. The existing research examining peer support interventions has reported promising evidence of the benefits of peer support. The purpose of our scoping review was to describe research on peer support for people living with HIV. We included 53 studies and sorted them into analytic categories and conducted descriptive analyses. The studies that were published between November/December 2000 and May 2021, had a range of study designs and heterogeneous priority groups, and included 20,657 participants from 16 countries. We identified 43 evaluations of the effe…

Secondary preventionChronic careMedical educationNursing (miscellaneous)VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801Process (engineering)Clinical study designPublic Health Environmental and Occupational HealthPsychological interventionHuman immunodeficiency virus (HIV)Peer supportmedicine.disease_causePeer reviewVDP::Medisinske Fag: 700::Helsefag: 800medicineVDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801PsychologyHealth Promotion Practice
researchProduct

Dissection of C1q Capability of Interacting with IgG

1997

Abstract C1q-bearing immune complexes have been observed in diseases such as rheumatoid arthritis and human immunodeficiency virus infection-associated neuropathy. For the purpose of understanding better the phenomenon of C1q-bearing immune complexes, we investigated the constancy of the C1q-IgG interaction. An enzyme-linked immunosorbent assay was developed in which wells were coated with IgG to mimic antigen-complexed IgG. Serial dilutions of C1q were applied for distinct time intervals, and bound C1q was detected either directly or after exposure to one of several elution buffers. Our results show that a part of C1q attached to IgG forms a tight association that is not reversible under t…

Serial dilutionElutionStereochemistryHuman immunodeficiency virus (HIV)chemical and pharmacologic phenomenaCell Biologyurologic and male genital diseasesmedicine.disease_causeBiochemistryLigand blottingchemistry.chemical_compoundfluids and secretionsImmune systemchemistryimmune system diseasesReagentmedicineUreaBiophysicsSodium dodecyl sulfateskin and connective tissue diseasesMolecular BiologyJournal of Biological Chemistry
researchProduct

Carbohydrate assimilation profiles of the first Italian Candida dubliniensis clinical isolates recovered from an HIV-infected individual.

2001

A total of six Candida dubliniensis isolates were obtained during 1 year of monitoring by monthly swabs from the oral cavity of an asymptomatic human immunodeficiency virus-infected individual in Catania, Italy. To the authors' knowledge, this constitutes the first recovery of C. dubliniensis from a human in Italy. Our identification procedure was based on colony color on CHROMagar Candida and carbohydrate assimilation profiles obtained by two commercial systems: API ID 32C and API 20C AUX. Karyotyping by pulsed-field gel electrophoresis confirmed the phenotypic identification. The biocodes obtained with API 20C AUX and with API ID 32C were 6172134 and 7142140015, respectively, for all six …

Settore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeHuman immunodeficiency virus (HIV)HIV InfectionsOral cavitymedicine.disease_causeMicrobiologyMicrobiologyFirst isolateCandidiasis OralHiv infectedGenotypemedicineHumansCandida albicansAssimilation profileMolecular BiologyCandidabiologyHIVGeneral MedicineFungi imperfectibacterial infections and mycosesequipment and suppliesbiology.organism_classificationCorpus albicansAIDSPhenotypeItalyCandida dubliniensiKaryotypingCarbohydrate MetabolismCandida dubliniensisResearch in microbiology
researchProduct

Evolution of syphilis incidence in Sibiu county (Romania) over a period of 10 years (2009-2018).

2021

Syphilis is the most common sexually transmitted disease that mainly affects socially active people, with a fluctuating worldwide incidence over the years. A retrospective study was conducted over a period of 10 years (2009-2018) that included 396 patients with syphilis diagnosed and monitored by Sibiu County Emergency Clinical Hospital, Romania. During this period (2009-2018), we observed a decrease in the new cases of syphilis by 35.90%, and the average syphilis incidence was 9.90 new cases per 100,000 inhabitants. Syphilis was diagnosed more frequently in men with an average age of 35.39 years, from urban areas, with and educational level of grades 9-12, unmarried, workers, or without oc…

Sexually transmitted diseaseCancer ResearchPediatricsmedicine.medical_specialtybusiness.industryIncidence (epidemiology)Human immunodeficiency virus (HIV)Retrospective cohort studyGeneral MedicineArticlesmedicine.diseasemedicine.disease_causeMen who have sex with menNeurosyphilisRegimenImmunology and Microbiology (miscellaneous)medicineSyphilisbusinessExperimental and therapeutic medicine
researchProduct

Binding isotope effects as a tool for distinguishing hydrophobic and hydrophilic binding sites of HIV-1 RT.

2014

The current treatment for HIV-1 infected patients consists of a cocktail of inhibitors, in an attempt to improve the potency of the drugs by adding the possible effects of each supplied compound. In this contribution, nine different inhibitors of HIV-1 RT, one of the three key proteins responsible for the virus replication, have been selected to develop and test a computational protocol that allows getting a deep insight into the inhibitors’ binding mechanism. The interaction between the inhibitors and the protein have been quantified by computing binding free energies through FEP calculations, while a more detailed characterization of the kind of inhibitor–protein interactions is based on …

StereochemistryBinding energyHuman immunodeficiency virus (HIV)Binding energyMolecular Dynamics Simulationmedicine.disease_causeLigandsIsotopesCatalytic DomainKinetic isotope effectDrug DiscoveryMaterials ChemistrymedicinePhysical and Theoretical ChemistryBinding siteBinding isotope effectsIsotopeChemistryWaterHIV Reverse TranscriptaseSurfaces Coatings and FilmsCrystallographyViral replicationHIV-1SolventsQuantum TheoryReverse Transcriptase InhibitorsThermodynamicsFree energiesHydrophobic and Hydrophilic InteractionsProtein BindingThe journal of physical chemistry. B
researchProduct

ChemInform Abstract: Synthesis of Glycopeptides with Lewisa Antigen Side Chain and HIV Peptide T Sequence Using the Trichloroethoxycarbonyl/Allyl Est…

2010

StereochemistryChemistryHuman immunodeficiency virus (HIV)Peptide TGeneral Medicinemedicine.disease_causeGlycopeptidechemistry.chemical_compoundBiochemistryAntigenmedicineSide chainProtecting groupSequence (medicine)ChemInform
researchProduct

Towards Waltheriones C and D: Synthesis of the Oxabicyclic Core

2017

A route to the oxabicyclic cores of the HIV cytoprotective quinolone alkaloids, waltheriones C and D, is described. The approach relies on a stereospecific transannular bromoetherification followed by reductive debromination. The route can also be rendered enantioselective via enzymatic reduction of a key intermediate (>99:1 er).

Stereospecificity010405 organic chemistryChemistryStereochemistryOrganic ChemistryEnantioselective synthesisHuman immunodeficiency virus (HIV)medicine010402 general chemistrymedicine.disease_cause01 natural sciencesCombinatorial chemistry0104 chemical sciencesSynlett
researchProduct

Frontispiece: Fluorine‐Containing Drugs Approved by the FDA in 2018

2019

Substitution reactionChemistryOrganic ChemistryHuman immunodeficiency virus (HIV)Cancerchemistry.chemical_elementFluorine containingGeneral Chemistrymedicine.diseasemedicine.disease_causeCombinatorial chemistryCatalysismedicineFluorineChemistry – A European Journal
researchProduct

“MIATA”—Minimal Information about T Cell Assays

2009

Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.

T-LymphocytesT cellmedicine.medical_treatmentImmunologyHuman immunodeficiency virus (HIV)medicine.disease_causeT cell responseCancer VaccinesArticleMonitoring ImmunologicNeoplasmsmedicineHumansImmunology and AllergyIn patientImmunoassaybusiness.industryViral VaccineCancerViral VaccinesImmunotherapymedicine.diseaseVaccinationInfectious Diseasesmedicine.anatomical_structureVirus DiseasesPractice Guidelines as TopicImmunologyImmunotherapybusinessCancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Humans; Immunoassay/standards; Immunotherapy; Monitoring Immunologic/standards; Neoplasms/therapy; Practice Guidelines as Topic/standards; T-Lymphocytes/immunology; Viral Vaccines/immunology; Viral Vaccines/therapeutic use; Virus Diseases/therapyImmunity
researchProduct

An Efficient Synthesis of Tenofovir (PMPA): A Key Intermediate Leading to Tenofovir-Based HIV Medicines

2020

Abstract: Herein, we report further improvements to the synthesis of tenofovir 1, the precursor to tenofovir disoproxil fumarate and tenofovir alafenamide fumarate. Starting from acyclic precursor diaminomalononitrile 12, a four-step protocol to tenofovir 1 will allow for vertical integration for more manufacturers. The key transformation is a more convergent one step procedure from 6 as compared to the current commercial process, with an improved yield from 59% (two steps) to 70%. Further improvements include eliminating the need for problematic magnesium tert-butoxide (MTB) and significant solvent reduction by eliminating the need for an intermediate workup. With the costs of HIV/AIDS tre…

Tenofovir010405 organic chemistrybusiness.industryOrganic ChemistryHuman immunodeficiency virus (HIV)Continuous manufacturingPharmacology010402 general chemistrymedicine.disease_causemedicine.disease01 natural sciencesTenofovir alafenamide0104 chemical sciencesAcquired immunodeficiency syndrome (AIDS)DiaminomaleonitrilemedicinePhysical and Theoretical ChemistrySecurity of supplybusinessmedicine.drug
researchProduct